瑞迈特收盘下跌1.12%，滚动市盈率42.73倍，总市值75.80亿元

Company Overview - Beijing Ruimait Medical Technology Co., Ltd. specializes in the manufacturing of medical devices and consumables in the respiratory health sector, with key products including various types of sleep breathing machines and monitoring devices [2] - The company holds a total of 633 domestic patents, including 107 invention patents, 390 utility model patents, and 136 design patents, as well as 202 international patents across multiple countries [2] Financial Performance - For the first quarter of 2025, the company reported a revenue of 265 million yuan, representing a year-on-year increase of 38.11%, and a net profit of 71.93 million yuan, up 44.11% year-on-year, with a gross profit margin of 49.57% [2] Market Position - As of June 9, the company's stock closed at 84.6 yuan, down 1.12%, with a rolling price-to-earnings (PE) ratio of 42.73 times, and a total market capitalization of 7.58 billion yuan [1] - In comparison to the medical device industry, which has an average PE ratio of 50.64 times and a median of 37.05 times, Ruimait ranks 85th in terms of PE ratio [1][3] Shareholding Structure - As of the first quarter of 2025, a total of 14 institutions held shares in Ruimait, including 6 funds, 5 other institutions, 2 brokerages, and 1 social security fund, with a total holding of 26.92 million shares valued at 2.172 billion yuan [1]